Source:http://linkedlifedata.com/resource/pubmed/id/11054755
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2000-11-21
|
pubmed:abstractText |
Intramuscular injections of botulinum toxin are the cornerstone of treatment for cervical dystonia. Controversy exists regarding the necessity for EMG-guided injections. We compared the clinical examination of four movement disorder specialists to an electromyographic (EMG) mapping study. Clinical predictions of individual muscle involvement were only 59% sensitive and 75% specific. Muscle hypertrophy, shoulder elevation, and dominant head vector did not bolster clinical accuracy. An EMG mapping study facilitates identification of dystonic muscles in cervical dystonia, which may enhance botulinum toxin therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0148-639X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 John Wiley & Sons, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1752-6
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:11054755-Adult,
pubmed-meshheading:11054755-Aged,
pubmed-meshheading:11054755-Aged, 80 and over,
pubmed-meshheading:11054755-Anti-Dyskinesia Agents,
pubmed-meshheading:11054755-Botulinum Toxins,
pubmed-meshheading:11054755-Cervical Vertebrae,
pubmed-meshheading:11054755-Electromyography,
pubmed-meshheading:11054755-Female,
pubmed-meshheading:11054755-Humans,
pubmed-meshheading:11054755-Male,
pubmed-meshheading:11054755-Middle Aged,
pubmed-meshheading:11054755-Predictive Value of Tests,
pubmed-meshheading:11054755-Reproducibility of Results,
pubmed-meshheading:11054755-Sensitivity and Specificity,
pubmed-meshheading:11054755-Torticollis
|
pubmed:year |
2000
|
pubmed:articleTitle |
Utility of an EMG mapping study in treating cervical dystonia.
|
pubmed:affiliation |
Department of Neurology, Mayo Clinic and Foundation, 200 2nd Street SW, Rochester, Minnesota 55905, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|